CorriXR Therapeutics

57 posts

CorriXR Therapeutics

@CorriXR

CorriXR is developing a #CRISPR gene editing platform to augment and improve current standard of care by genetically knocking out cancer drug resistance.

Newark, DE Katılım Ekim 2023

25 Takip Edilen20 Takipçiler

CorriXR Therapeutics@CorriXR·17 Mar

CorriXR will be attending BIO-Europe Spring in Lisbon on March 23-25. Schedule a partnering meeting with Jan Case and Natalia Rivera-Torres to learn how our gene ablation approach for squamous cell carcinomas overcomes barriers to effective cancer treatment. #BioEuropeSpring #BIOEurope #oncology

English

CorriXR Therapeutics@CorriXR·23 Oca

Our preclinical study just published in Molecular Therapy Oncology shows that #CRISPR-Cas9-mediated NRF2 disruption restores chemosensitivity in head and neck and esophageal squamous cell carcinoma models - extending our previous findings in lung cancer. These results support our plan to file an IND for #HNSCC - the first clinical application of our platform. #oncology #geneediting businesswire.com/news/home/2026…

English

CorriXR Therapeutics retweetledi

Del Biz Roundtable@DelawareBRT·12 Oca

Congrats @CorriXR 🥳👏 The #Delaware life science startup inked a deal to develop a pioneering inhalable therapy to treat lung cancer. delawarebusinesstimes.com/news/corrixr-a…

English

110

CorriXR Therapeutics@CorriXR·2 Ara

Combining CorriXR’s groundbreaking #CRISPR platform with @inhatarget pulmonary #LNP drug delivery and @MRXdevices #inhalation device technology has the potential to reshape the landscape of #lungcancer treatment. #oncology #geneediting businesswire.com/news/home/2025…

English

CorriXR Therapeutics@CorriXR·17 Kas

CorriXR is using #geneediting to make tumor cells more responsive to chemotherapy and slow tumor growth. Our collaborators @GeneEditingDE just published a study in @MolTherapy #Oncology during 🫁National Lung Cancer Awareness Month that sets a strong foundation for moving towards clinical trials for treatment in #lungcancer – and beyond to other tumor types. #CRISPR businesswire.com/news/home/2025…

English

CorriXR Therapeutics@CorriXR·30 Eki

Congratulations to @RobertFerrisMD, a member of the CorriXR Clinical Advisory Board, on his election to the National Academy of Medicine!

UNC Lineberger@UNC_Lineberger

Huge congratulations to @RobertFerrisMD, PhD, UNC Lineberger executive director and Samantha Meltzer‑Brody, MD, MPH, executive dean of @UNC_SOM, on their election to the National Academy of Medicine (@theNAMedicine) - one of the highest honors in health and medicine. 🏆 Ferris and Meltzer-Brody are the only physicians in North Carolina elected to the Academy this year. Election to the Academy recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. We’re incredibly proud to have such visionary leaders working to advance patient care, research and innovation not just here in North Carolina, but around the world. news.unchealthcare.org/2025/10/ferris…

English

CorriXR Therapeutics retweetledi

Philadelphia Business Journal@PHLBizJournal·16 Eki

With a new COO and several consultants that were formerly as Spark Therapeutics, CorriXR plans on "rewriting the rules of cancer treatment." bizjournals.com/philadelphia/n…

English

335

CorriXR Therapeutics retweetledi

Jill Castilla@JillCastilla·9 Eki

It’s a whirlwind week! From @CorriXR board meeting to moderating @ChicagoFed Payments Conference to interviewing @blackstone CEO at @federalreserve community bank conference, woah! BTW, CorriXR’s CEO, Dr. Kmiec, has the most incredible swag in his office - so many patents!

English

800

CorriXR Therapeutics retweetledi

Governor Matt Meyer@MattMeyerDE·20 Ağu

Investing in Delaware’s innovators means investing in a healthier future. Newark-based CorriXR Therapeutics just received a $1M state grant to advance groundbreaking cancer gene-editing therapies—supporting local jobs, cutting-edge science, and life-saving treatments. Learn more: newarkpostonline.com/news/newark-co…

English

590

CorriXR Therapeutics@CorriXR·4 Ağu

Exciting news! CorriXR has been selected to present our next generation treatment for solid tumors at the @LifeSciencesPA conference on Sept 25/26. #oncology #geneediting #CRISPR

English

CorriXR Therapeutics@CorriXR·18 Haz

Attending #BIO2025? Don't miss CorriXR's presentation on our next generation treatment for solid tumors on June 19 at 10:30 AM in Room 153B. #oncology #geneediting #CRISPR

English

CorriXR Therapeutics@CorriXR·28 May

COO Jan Case will present CorriXR's next generation treatment for solid tumors at #BIO2025 on June 19 at 10:30 AM in Room 153B. #oncology #geneediting #CRISPR app.sosha.ai/s/dI66Jvzp

English

CorriXR Therapeutics@CorriXR·5 May

CorriXR Founder & CEO Eric Kmiec, Ph.D. will be presenting at the @BioNJ_Org BioPartnering Conference next week. #BioPartnering2025 #oncology #CRISPR #biotech #geneediting

English

CorriXR Therapeutics@CorriXR·4 Nis

Founder & CEO Eric Kmiec is presenting on the role #CRISPR can play in novel #oncology treatments at the @CrisprMedicine conference next week. We hope to see you there! #CRISPRMED25

English

299

CorriXR Therapeutics@CorriXR·2 Mar

Attending #CRISPRMED25? DM us to schedule a meeting with CorriXR Founder & CEO Eric B. Kmiec to learn more about our novel approach to treating solid tumors. #GeneEditing #CRISPR #oncology #biotech

English

CorriXR Therapeutics@CorriXR·28 Şub

CorriXR welcomes Michael Alexander to our leadership team! #oncology #geneediting #biotech #CRISPR

English

CorriXR Therapeutics@CorriXR·8 Oca

Thrilled to announce that Jan Case has joined our team as COO. Her proven skills and expert guidance will help us achieve our goal of significantly improving the lives of people living with cancer. #CRISPR #geneediting #oncology #biotech businesswire.com/news/home/2025…

English

CorriXR Therapeutics@CorriXR·3 Oca

CorriXR named one of 4 companies to watch in the accelerating #geneediting race by @Clarivate @PharmaVoice #CRISPR #Oncology #biotech pharmavoice.com/news/biotech-w…

English

Keşfet

@inhatarget @MRXdevices @GeneEditingDE @MolTherapy @RobertFerrisMD @ChicagoFed @blackstone @federalreserve